Filament Health Corp. announced a non-brokered private placement of up to 22,222,222 units at a price of CAD 0.09per share for the aggregate gross proceeds of CAD 2,000,000 led by returning investor, Negev Capital on July 19, 2023. Each unit will consist of one common share and one common share purchase warrant.

Each warrant will be exercisable to acquire one common share for a period of 36 months following the closing date of the offering at an exercise price of CAD 0.117 representing a 30% premium to the issue price. All the securities issued thereunder will be subject to a four month hold period under securities laws. The securities offered in the offering have not been, nor will they be, registered under the Securities Act.

The transaction is subject to the approval of the NEO Exchange and regulatory authorities.